Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical composition for treating cardiovascular diseases containing 3-(2,2,2-trimethylhydrazinium)propionate and .gamma.-butyrobetaine

Pharmaceutical composition for treating cardiovascular diseases containing 3-(2,2,2-trimethylhydrazinium)propionate and .gamma.-butyrobetaine

US Patent 5859056 · Granted Jan 12, 1999

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

N-carbamoylmethyl-4-(R)-phenyl-2-pyrrolidinone, method of its preparation and ph2016
N-Carbamoylmethy1-4-(R)-phenyl-2-pyrrolidinone, method of its preparation and ph2015
Acetylsalicylic acid salts2014
Pharmaceutical combination of 5-fluorouracil and derivate of 1,4-dihydropyridine2013
Method for preparation of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid2012
Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitor2011
Substituted pyrazolo[1,5-A]pyrimidines as metabotropic glutamate receptor modula2011
Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors2011
Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modula2011
Carbamic acid compounds comprising an amide linkage as HDAC inhibitors2011
Pharmaceutical composition on basis of reverse transcriptase inhibitor and meldo2010
Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitor2010